Maruho Report 2021
22/58

20iniks seriesiniks official social media accountfacebookinstagramCarté HD seriesCarté HD official social media accountfacebookArthroscopic rotator cuff repair instrumentitto CSP v2Meeting at Kose Maruho PharmainstagramtwitterFor medical devices, Maruho’s know-how in pharmaceuticals and Maruho Hatsujyo Kogyo’s precision metal processing technology are combined to develop the business, leveraging the strengths of the two companies. In 2020, Maruho Hatsujyo Kogyo’s business for MAKIZUME MEISTER, a device for pincer nails, was assigned to Maruho. Maruho launched Meister Aid, a nail cuticle remover to assist wearing of MAKIZUME MEISTER, in April 2021. Meister Aid is a product unique to the Maruho Group. Maruho identified and analyzed medical needs, to which Maruho Hatsujyo Kogyo gave shape using its metal processing technology. In 2020, Maruho made Maruho Medical, Inc. (U.S.), a subsidiary of Maruho Hatsujyo Kogyo, a fully owned subsidiary of Maruho. After advancing the development Aiming to support many more people by engaging not only pharmaceuticals but also day-to-day skin care, in 2014 Maruho launched iniks, a skin-care brand for people with sensitive skin or acne. The brand covers the three skin-care steps of “wash,” “moisturize,” and “protect,” collectively named the “Skin Care Trinity,” and provides care for common skin troubles in adults, such as dry skin, sensitive skin, acne, and other problems caused by emotional changes and stress. The lineup currently includes makeup remover, facial wash, toner, milky lotion, sunscreen, and foundation, and will be expanded in close cooperation with dermatologists to properly respond to the needs of people suffering from skin troubles.of a modified version of Maruho Medical’s arthroscopic rotator cuff repair instrument, Maruho released the itto CSP v2 to be used mainly for shoulder joint surgeries of active seniors. Maruho plans to expand the product lineup in Japan after confirming that surgeries using this instrument have been established as a standard in the U.S. market. In July 2019, Maruho established Kose Maruho Pharma Co., Ltd. jointly with KOSÉ Corporation, a major cosmetics manufacturer in Japan. Kose Maruho Pharma aims to support comprehensive skin care, from daily maintenance and preventive care with quasi-pharmaceuticals to self-treatment with OTC drugs, tailored to every customer according to their symptoms and needs, as well as their skin condition, which changes every day. The Carté HD series, a high-performance skin-care brand released in September 2020 achieved a profit in its first year. The series has won over 40 cosmetics awards for its excellent moisturizing effect and usability. Kose Maruho Pharma will continue to enhance the Carté HD series and work to increase its brand appeal.Developing the medical devices businessDeveloping the self-care business

元のページ  ../index.html#22

このブックを見る